Richard Close
Stock Analyst at Canaccord Genuity
(4.63)
# 847
Out of 4,411 analysts
623
Total ratings
50.8%
Success rate
11.3%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HNGE Hinge Health | Rated: Buy | $65 → $76 | $67.81 | +12.08% | 12 | Jun 15, 2026 | |
| HCAT Health Catalyst | Maintained: Buy | $2 | $1.76 | +13.96% | 32 | Jun 4, 2026 | |
| CLOV Clover Health Investments | Maintained: Buy | $3.2 → $4.2 | $4.94 | -14.98% | 28 | Jun 4, 2026 | |
| CTEV Claritev | Initiated Coverage: Buy | $32 | $30.67 | +4.34% | 1 | May 29, 2026 | |
| PHR Phreesia | Maintained: Buy | $22 → $16 | $9.44 | +69.49% | 23 | May 28, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $34 | $23.53 | +44.50% | 25 | May 28, 2026 | |
| PGNY Progyny | Upgraded: Buy | $19 → $30 | $26.60 | +12.78% | 19 | May 19, 2026 | |
| DOCS Doximity | Maintained: Buy | $34 → $30 | $20.89 | +43.61% | 27 | May 14, 2026 | |
| EVH Evolent Health | Maintained: Buy | $4 → $6 | $4.70 | +27.66% | 78 | May 12, 2026 | |
| TALK Talkspace | Maintained: Hold | $5.25 | $5.20 | +0.96% | 10 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1 | $0.5803 | +72.32% | 20 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $8.62 | +27.61% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $17.11 | +40.27% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $21 → $24 | $25.78 | -6.90% | 62 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $16 | $10.14 | +57.79% | 27 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $7.57 | +32.10% | 75 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $18.38 | +63.22% | 10 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 → $13 | $0.0001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $110 | $150.99 | n/a | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.5 → $2 | $0.0001 | n/a | 28 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $83 | $61.20 | n/a | 45 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $21 | $4.80 | n/a | 60 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $24 | $21.62 | n/a | 12 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 | $22.80 | n/a | 1 | Feb 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 | $161.71 | n/a | 1 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 | $26.12 | n/a | 1 | Sep 11, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $227.72 | n/a | 1 | Nov 18, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $20 | $7.55 | n/a | 1 | Nov 23, 2009 |
Hinge Health
Jun 15, 2026
Rated: Buy
Price Target: $65 → $76
Current: $67.81
Upside: +12.08%
Health Catalyst
Jun 4, 2026
Maintained: Buy
Price Target: $2
Current: $1.76
Upside: +13.96%
Clover Health Investments
Jun 4, 2026
Maintained: Buy
Price Target: $3.2 → $4.2
Current: $4.94
Upside: -14.98%
Claritev
May 29, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $30.67
Upside: +4.34%
Phreesia
May 28, 2026
Maintained: Buy
Price Target: $22 → $16
Current: $9.44
Upside: +69.49%
Privia Health Group
May 28, 2026
Maintained: Buy
Price Target: $34
Current: $23.53
Upside: +44.50%
Progyny
May 19, 2026
Upgraded: Buy
Price Target: $19 → $30
Current: $26.60
Upside: +12.78%
Doximity
May 14, 2026
Maintained: Buy
Price Target: $34 → $30
Current: $20.89
Upside: +43.61%
Evolent Health
May 12, 2026
Maintained: Buy
Price Target: $4 → $6
Current: $4.70
Upside: +27.66%
Talkspace
May 12, 2026
Maintained: Hold
Price Target: $5.25
Current: $5.20
Upside: +0.96%
May 12, 2026
Maintained: Hold
Price Target: $1
Current: $0.5803
Upside: +72.32%
May 8, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $8.62
Upside: +27.61%
May 8, 2026
Maintained: Buy
Price Target: $22 → $24
Current: $17.11
Upside: +40.27%
May 6, 2026
Rated: Hold
Price Target: $21 → $24
Current: $25.78
Upside: -6.90%
May 6, 2026
Maintained: Buy
Price Target: $14 → $16
Current: $10.14
Upside: +57.79%
Apr 30, 2026
Maintained: Buy
Price Target: $10
Current: $7.57
Upside: +32.10%
Apr 30, 2026
Maintained: Buy
Price Target: $30
Current: $18.38
Upside: +63.22%
Mar 10, 2023
Maintained: Buy
Price Target: $50 → $13
Current: $0.0001
Upside: n/a
Feb 27, 2023
Maintained: Hold
Price Target: $110
Current: $150.99
Upside: n/a
May 12, 2022
Maintained: Hold
Price Target: $2.5 → $2
Current: $0.0001
Upside: n/a
Nov 19, 2021
Maintained: Hold
Price Target: $89 → $83
Current: $61.20
Upside: n/a
Nov 8, 2021
Maintained: Buy
Price Target: $18 → $21
Current: $4.80
Upside: n/a
Aug 4, 2021
Maintained: Buy
Price Target: $22 → $24
Current: $21.62
Upside: n/a
Feb 22, 2019
Maintained: Hold
Price Target: $33
Current: $22.80
Upside: n/a
Mar 1, 2018
Reiterated: Buy
Price Target: $135
Current: $161.71
Upside: n/a
Sep 11, 2013
Downgraded: Hold
Price Target: $55
Current: $26.12
Upside: n/a
Nov 18, 2010
Maintained: Hold
Price Target: n/a
Current: $227.72
Upside: n/a
Nov 23, 2009
Upgraded: Hold
Price Target: $20
Current: $7.55
Upside: n/a